TARDBP and amyotrophic lateral sclerosis: Liraglutide treatment did not, however, improve motor function in SOD1G93A and TAR DNA-binding protein [43] (TDP-43)Q331K transgenic Amyotrophic lateral sclerosis (ALS) mice models, according to earlier investigations [50].